Crispr gene-editing revolution treats internal organ for first time – Financial Times

A US start-up has successfully treated the first patients using a Crispr gene-editing therapy directed inside the body to an internal organ.
The early trial data from Intellia Therapeutics, co-foun… [+3002 chars]